Chiklita ad

Showing posts with label Metformin. Show all posts
Showing posts with label Metformin. Show all posts

Wednesday, 28 February 2018

Diabetes drug increases the weight of fetus


When pregnant women take the common diabetes medication metformin throughout pregnancy, it can positioned their kids at increased hazard of having weight problems or obese. Many pregnant women are taking metformin to deal with gestational diabetes or polycystic ovary syndrome PCOS. PCOS increases the risk of developing diabetes and other metabolic problems.

When pregnant women with PCOS or gestational diabetes take metformin, it crosses the placenta and passed to the fetus. According to Liv Guro Engen Hanem, M.D., of the Norwegian University of Science and Technology in Trondheim, Norway, the children of pregnant women who took metformin or placebo during pregnancy are at risk of weight gain.

Researchers invited parents of 292 children who participated in previous randomized scientific trials to be part of the study. In the preceding trials, pregnant women with PCOS were assigned to take either metformin or a placebo during pregnancy, the researchers wound up reviewing frame mass index BMI and other measurements for 161 children born following the advance studies.

At age four, the children whose mothers had been randomized to metformin at some point of being pregnant tended to weigh greater than the children whose mother took the placebo despite the fact that metformin did not appear to have an effect on birth weight, the trend became apparent whilst children reached six months of age. At age four, the children in metformin group had higher BMI scores and were much more likely to satisfy the criteria for weight problems or overweight than children in placebo group.
          haleplushearty.blogspot.com

Monday, 22 May 2017

Cure for type 2 diabetes


Type 2 diabetes is currently controlled by insulin injections, healthy diet, regular exercise and monitoring blood glucose levels.

Two studies by the University of Adelaide have demonstrated for the first time how potential new anti-diabetic drugs could target the body at the molecular level to treat the condition.

Currently the most commonly prescribed anti-diabetic drug is Metformin, which acts on the liver to reduce glucose production.

However, these new drugs work completely differently by targeting a protein receptor known as PPARgamma found in fat tissue throughout the body, and then either fully or partially activating it to lower blood sugar.

It does this by increasing insulin and changing the metabolism of fat and sugar. This make it efficient at reducing blood sugar.